Biological Implants

Published by: RI Technologies

Published: Jan. 1, 2008 - 265 Pages

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

1. Foreword

Biological Implants - A Revolutionary Human Repair Technique

Segmentation of Biological Implants

Exhibit 1: Segmentation of Global Biological Implants Market by Tissue/Muscle (Orthopedic, Soft Tissue, Cardiovascular, and Other*), by Origin (Allograft and Xenograft) and by Mode of Administration (Surgical and Injectable)

2. Global Market Analysis

Exhibit 2: Biological Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Medical Implants

An Overview of Medical Implants

History of Implants

The Need for a Better Implant

Naturally Derived Implants

Orbital Implants and Artificial Eyes

Artificial Skin

Hip Replacement

Tissues

Animal Tissues

Plant Tissues

Definitions

Implant

Transplant

Explant

Types of Implants

Artificial Implants

Biological Implants

Tissue Engineering

Market Analysis of Tissue/Muscle Biological Implants by Geographic Region

Orthopedic

Exhibit 3: Orthopedic Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 4: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

Soft Tissue

Exhibit 5: Soft Tissue Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 6: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

Cardiovascular

Exhibit 7: Cardiovascular Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 8: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

Other (Dental, Ophthalmic and Urologic)

Exhibit 9: Biological Implants in Other Tissue/Muscle (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 10: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

Market Analysis of Origin by Geographic Region

Allograft

Exhibit 11: Allograft Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 12: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

Xenograft

Exhibit 13: Xenograft Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 14: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

Market Analysis of Mode of Administration by Geographic Region

Surgical

Exhibit 15: Surgical Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 16: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

Injectable

Exhibit 17: Injectable Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 18: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

Exhibit 19: List of Major Global Companies

3. Regional Market Analysis

North America

Exhibit 20: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Major Companies in North America

Aastrom Biosciences, Inc. (USA)

Alphatec Spine, Inc. (USA)

CONMED Linvatec (USA)

CryoLife®, Inc. (USA)

Curis, Inc. (USA)

Exactech, Inc. (USA)

Fascia Biosystems LLC (USA)

Inamed Aesthetics (USA)

Integra Lifesciences Corporation (USA)

IOP, Inc. (USA)

LifeCell Corporation (USA)

Nuvasive, Inc (USA)

Organogenesis, Inc. (USA)

Osteotech, Inc. (USA)

Pegasus Biologics, Inc. (USA)

QLT Inc. (Canada)

Stryker Corporation (USA)

Tutogen Medical, Inc. (USA)

Market Analysis by Tissue / Muscle Biological Implants in North America

Ortopedic

Exhibit 21: Ortopedic Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)

Exhibit 22: Ortopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)

SoftTissue

Exhibit 23: SoftTissue Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)

Exhibit 24: SoftTissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)

Cardiovascular

Exhibit 25: Cardiovascular Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)

Exhibit 26: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)

Other (Dental, Ophthalmic and Urologic)

Exhibit 27: Biological Implants in Other Tissue/Muscle (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)

Exhibit 28: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)

Market Analysis by Origin in North America

Allograft

Exhibit 29: Allograft Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)

Exhibit 30: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)

Xenograft

Exhibit 31: Xenograft Biological Implants (2005-2012) - North American Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)

Exhibit 32: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)

Market Analysis by Mode of Administration in North America

Surgical

Exhibit 33: Surgical Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)

Exhibit 34: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)

Injectable

Exhibit 35: Injectable Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)

Exhibit 36: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)

Europe

Exhibit 37: Biological Implants (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Major Companies in Europe

M Arthro Kinetics plc (UK)

Asterand Plc (UK)

AutoTissue GmbH (Germany)

BioTissue Technologies AG (Germany)

Market Analysis by Tissue / Muscle in Europe

Orthopedic

Exhibit 38: Orthopedic Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 39: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)

Soft Tissue

Exhibit 40: Soft Tissue Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 41: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)

Cardiovascular

Exhibit 42: Cardiovascular Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 43: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)

Other (Dental, Ophthalmic and Urologic)

Exhibit 44: Biological Implants in Other Tissue / Muscle(2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 45: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)

Market Analysis by Origin in Europe

Allograft

Exhibit 46: Allograft Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 47: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)

Xenograft

Exhibit 48: Xenograft Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 49: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)

Market Analysis by Mode of Administration in Europe

Surgical

Exhibit 50: Surgical Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 51: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)

Injectable

Exhibit 52: Injectable Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 53: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)

Asia-Pacific

Exhibit 54: Biological Implants (2005-2012) -Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Major Companies in Asia-Pacific

bioMD Limited (Australia)

Maxigen Biotech, Inc. (Taiwan)

Market Analysis by Tissue / Muscle in Asia-Pacific

Orthopedic

Exhibit 55: Orthopedic Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 56: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)

Soft Tissue

Exhibit 57: Soft Tissue Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 58: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)

Cardiovascular

Exhibit 59: Cardiovascular Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 60: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)

Other (Dental, Ophthalmic and Urologic)

Exhibit 61: Biological Implants in Other Tissue / Muscle (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 62: Biological Implants in Other Tissue / Muscle (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)

Market Analysis by Origin in Asia-Pacific

Allograft

Exhibit 63: Allograft Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 64: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)

Xenograft

Exhibit 65: Xenograft Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 66: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)

Market Analysis by Mode of Administration in Asia-Pacific

Surgical

Exhibit 67: Surgical Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 68: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)

Injectable

Exhibit 69: Injectable Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 70: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)

Rest of World

Exhibit 71: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)

Market Analysis by Tissue/Muscle in Rest of World

Orthopedic

Exhibit 72: Orthopedic Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)

Exhibit 73: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World (Graphical Representation Included)

Soft Tissue

Exhibit 74: Soft Tissue Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 75: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

Cardiovascular

Exhibit 76: Cardiovascular Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)

Exhibit 77: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

Other (Dental, Ophthalmic and Urologic)

Exhibit 78: Biological Implants in Other Tissue / Muscle (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)

Exhibit 79: Biological Implants in Other Tissue / Muscle (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

Market Analysis by Origin in Rest of World

Allograft

Exhibit 80: Allograft Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)

Exhibit 81: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

Xenograft

Exhibit 82: Xenograft Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)

Exhibit 83: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

Market Analysis by Mode of Administration in Rest of World

Surgical

Exhibit 84: Surgical Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)

Exhibit 85: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

Injectable

Exhibit 86: Injectable Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)

Exhibit 87: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

III. PRODUCT/TECHNOLOGY RESEARCH

1. Introduction

Biological Implants Growth Trends - Global Markets

Exhibit 88: Global Market for Biological Implants: Geographic Regions (North America, Europe, Asia-Pacific, Rest of World) Ranked by Projected CAGR for 2005 through 2012(Graphical Representation Included)

Types of Biological Implants

Application Biological Implants

Function and Use of Biological Implants

Application of Biological Implants in ENT surgery

Location of the Bioimplant: Middle Ear

Ossicle Replacement Draws Mixed Response

Tympanoplasty

Traumatic Perforation Using Fibrin-coated Collagen

Location of the Bioimplant: Paranasal Sinuses and Cranial Bones

Orbital Wall Reconstructions Using Allogenic Materials

Location of the Bioimplant: Bone and Cartilage of the Nose

Allogenic Materials to Develop Cartilage

Septal Abscess

Soft Tissue Implants

Location of the Bioimplant: Base of the Skull

Allogenic Materials to Treat Dural Defects

Allogenic Materials Required to Accomplish Duraplasty

The Application of Fibrin Glues in ENT Surgeries

Location of the Bioimplant: Trachea/Larynx

The Replacement of Trachea Using Solvent-preserved Allogenic Variety of Trachea

The Various Disorders of Vocal Cord

Location of the Bioimplant: Skin

The Process of Skin Replacement

Wrinkle Lift Treatment

2. Segmentation of Biological Implants

Segmentation by Tissue/Muscle

Growth Trends - Global Market for Biological Implants by Tissue /Muscle

Exhibit 89: Global Market for Biological Implants by Tissue / Muscle (Other, Soft Tissue, Orthopedic, and Cardiovascular) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Soft Tissue Biological Implants

Growth Trends - Global Market for Soft Tissue Biological Implants

Exhibit 90: Global Market for Soft Tissue Biological Implants: Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by projected CAGR for 2005 through 2012 (Graphical Representation Included)

Biological Implants in Cosmetic Surgery

Lip Augmentation Using Bioimplants

Allograft Implants Used in Lip Augmentation

Types and Characteristics of Various Allograft Implants

Alloderm

Apligraft

Cosmoderm 1 & 2

Cosmoplast

Cymetra or Micronized Alloderm

Fascian

Surgisis Soft Tissue Graft & Surgisis ES Soft Tissue Graft

Self Derived [Autologous] Implants & Injectables

Types and Characteristics of Autologous Implants

Autologen

Dermis Grafts

Dermis Fat Grafts

Fascia Grafts

Fat Grafting, Transfer or Transplanting

Isolagen

Scar Tissue Grafting

Tendon Grafting

Cosmetic Surgery

Global Market Analysis for Cosmetic Surgery

Exhibit 91: Cosmetic Surgery (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 92: Cosmetic Surgery (2005-2012) - Global Market Analysis (Current & Future) for Cosmetic Surgery in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 93: Cosmetic Surgery (2006, 2009 and 2012) - Percentage Breakdown for Cosmetic Surgery in US, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)

Orthopedic Biological Implants

Growth Trends - Global Market for Orthopedic Biological Implants

Exhibit 94: Global Market for Orthopedic Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Bone Graft Substitutes

Osteoinductive Agents - Substitute for Bone Allografts

Fibrin Matrix

Cardiovascular Biological Implants

Growth Trends - Global Market for Cardiovascular Biological Implants

Exhibit 95: Global Market for Cardiovascular Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Other (Dental, Ophthalmic, Urologic)

Growth Trends - Global Market for Biological Implants in Other Tissue/Muscle

Exhibit 96: Global Market for Biological Implants in other Tissue/Muscle: Geographic Region (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Other Tissue/Muscle Biological Implant Products

Ophthalmic Biological Implants

3. Segmentation by Origin of Biological Implants

Growth Trends - Global Market for Biological Implants by Origin

Exhibit 97: Global Market for Biological Implants by Origin (Xenograft, Alloraft) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Allograft and Xenograft Biological Implants

Autografts and their Limitations

Utilization of the Allograft Bone Tissue

Limitations of the Process

Few Disadvantages of Using Allografts

Preventive Measures for Warding Infection

Bone Grafting

Xenografts

Using Valved Porcine Xenografts in the Right Ventricle Outlet for Congenital Anomalies

Other Avenues of Research

The L-Hydro Method

Allograft Biological Implants

Growth Trends - Global Market for Allograft Biological Implants

Exhibit 98: Global Market for Allograft Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Xenograft Biological Implants

Growth Trends - Global Market for Xenograft Biological Implants

Exhibit 99: Global Market for Xenograft Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Allograft Bone Tissue - Processing

Preparation for Biotransplantation

Allograft Bone Tissue

Base Tissue Segment

The Processing of Allograft Bone Tissue

Processing of Grafton® DBM - A Biological Implant Product of Osteotech

CXC Technology

The Process of Tissue Processing Using Tutogen

The Process of Manufacture and Processing of Allografts

Stentless Porcine Xenograft (Mitral Valve Replacement)

4. Segmentation by Mode of Administration

Growth Trends - Global Market for Biological Implants by Mode of Administration

Exhibit 100: Global Market for Biological Implants by Mode of Administration (Injectable and Surgical) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Injectable Biological Implants

Growth Trends - Global Market for Injectable Biological Implants

Exhibit 101: Global Market for Biological Implants by Mode of Administration : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Injectable Fillers for Soft Tissue Augmentation

Types of Augmentation Materials

Osteogenic Injectable Bone Substitutes

Surgical Biological Implants

Growth Trends - Global Market for Surgical Biological Implants

Exhibit 102: Global Market for Surgical Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

5. Product Trends

Research and Development

Neovascularisation Promoting Membrane for Biological Implants

Biological Implants of Semipermeable Amphiphilic Membranes

Artificial Tissue Systems

Stem Cells in Biological Implants

The Journey of Embryonic Stem Cells from Fundamental Biology to Medicine

Application of Umbilical Cord Lining Cells as Therapeutic Bioimplants for Metabolic Disorders

Drug Delivery and Smart Biological Implants

Tissue Engineered Biological Implants

Biological Implants Treatment of Vocal Fold Disorders

Systemic Inhibition of Tumor Growth using Biological Implants

Process of Secretion and Expression of TSP-2 using Polymer-Cell Grafts in Vivo

Inhibition of Tumor Growth in Mice Containing TSP-2-secreting Bioimplants.

Inhibition of Tumor Angiogenesis in Mice Containing TSP-2-secreted Bioimplants

Surgery for Valvular Heart Disease

RVOT Reconstruction

Bovine Valved Venous Xenografts for RVOT Reconstruction

Alloplastic Implants for Treatment of Stress Urinary Incontinence

Repair of Cartilage Lesions

Repair of Cartilage Lesions Using Biological Implants - A Comparative Histological and

Biomechanical Study in Goats

Cryopreservation of Human Ovarian Tissues

ADAPT (Advanced Tissue Process) - CXC Technology

Clinical Trials

Man Implanted with Teeth obtained from shoulder!!!!

Implantation of Esterified Hyaluronic Acid in Microdissected Reinke’s Space

Healing of Brain and Bones

Saving Brain and Spines

The Perfect Knee

Get the Smile Back on Your Face

Mending Broken Hearts

Biological Implants in Sports Medicine

Allografts in Sports

Transplantation Genetics

Acceptance of Biological Implants

Biphasic Implants

Preparation of a Biphasic Scaffold

Devising Biological Implants for Healing of Joint Disorders

Biomaterials

The Construction of New Body Parts

Orthopedic Biomaterials

Heart Valve Biomaterials

Risk of Infection, Off - Label Use and Safety

Table: Different Processes Used for Preservation of Allografts and Xenografts

Ethical Issues Concerning Biological Implants

Moral Issue and Balancing Concept

Animal Rights

“Speciesism”

Rights

Objectivity

Practical Issue

Animal-to-Human Transplantation

IV. MARKET DYNAMICS

1. Market Overview

Global Market Analysis for Implants

Exhibit 103: Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Global Market Analysis for Spinal Implants

Exhibit 104: Spinal Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 105: Spinal Implants (2005-2012) - Global Market Analysis (Current & Future) for Implants in US, Europe, Asia, Canada and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 106: Spinal Implants (2006, 2009 and 2012) - Percentage Breakdown for Implants in USA, Europe, Asia-Pacific, Canada and Rest of World (Graphical Representation Included)

Global Market Analysis for Orthopedic Implants

Exhibit 107: Orthopedic Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 108: Orthopedic Implants (2005-2012) - Global Market Analysis (Current & Future) for Orthopedic Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 109: Orthopedic Implants (2006, 2009 and 2012) - Percentage Breakdown for Orthopedic Implants in USA, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)

Global Market Analysis for Cardiovascular Implants

Exhibit 110: Cardiovascular Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 111: Cardiovascular Implants (2005-2012) - Global Market Analysis (Current & Future) for Cardiovascular Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 112: Cardiovascular Implants (2006, 2009 and 2012) - Percentage Breakdown for Cardiovascular Implants in USA, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)

Global Market Analysis for Dental Implants

Exhibit 113: Dental Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 114: Dental Implants (2005-2012) - Global Market Analysis (Current & Future) for Dental Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 115: Dental Implants (2006, 2009 and 2012) - Percentage Breakdown for Dental Implants in US, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)

Global Market Analysis for Biological Implants

Exhibit 116: Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 117: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

Global Market Analysis by Tissue/Muscle

Exhibit 118: Biological Implants (2005-2012): Global Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 119: Biological Implants (2006, 2009 and 2012): Percentage Breakdown of Global Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other (Graphical Representation Included)

Global Market Analysis by Origin

Exhibit 120: Biological Implants (2005-2012): Global Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 121: Biological Implants (2006, 2009 and 2012): Percentage Breakdown of Global Market Value by Origin for Allograft and Xenograft

Global Market Analysis by Mode of Administration

Exhibit 122: Biological Implants (2005-2012): Global Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 123: Biological Implants (2006, 2009 and 2012): Percentage Breakdown of Global Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

2. Market Trends

3. Major Companies in Biological Implants Industry

Aastrom Biosciences, Inc. (USA)

Alphatec Spine, Inc. (USA)

Arthro-Kinetics Plc (UK)

Asterand Plc (UK)

AutoTissue GmbH (Germany)

bioMD Limited (Australia)

BioTissue Technologies AG (Germany)

CONMED Linvatec (USA)

CryoLife, Inc. (USA)

Curis, Inc. (USA)

Exactech, Inc. (USA)

Fascia Biosystems LLC (USA)

Inamed Aesthetics (USA)

Inion OY (Finland)

Integra Lifesciences Corporation (USA)

IOP, Inc. (USA)

LifeCell Corporation (USA)

Maxigen Biotech, Inc. (Taiwan)

NuVasive Inc. (USA)

Organogenesis, Inc. (USA)

Osteotech, Inc. (USA)

Pegasus Biologics, Inc. (USA)

QLT, Inc. (Canada)

Stryker Corporation (USA)

Tutogen Medical, Inc. (USA)

4. Major Activities in Biological Implants Industry

Organogenesis Inc. Signs MoU with National Tissue Engineering Center of China

Tutogen Medical, Inc. Signs New Tissue Supply Agreement and Extends Existing Agreement

Regeneration Technologies Merges with Tutogen Medical

Integra Creates a New Global Leader in Orthobiologics with New Acquisition (IsoTis)

Osteotech Signs Tissue Supply Agreement with LifeNet Health

RTI Introduces New BioCleanse® Meniscus

Mentor Launches New NeoForm™ Dermis for Breast Reconstruction

LifeCell Corporation Receives 510(k) Clearance for New Soft Tissue Repair Product

RTI Signs Distribution and Supply Agreement with Stryker Corporation

Inion Granted with US Patent for Bioactive Materials Technology

Tutogen Medical Signs an International Distribution Agreement with Coloplast Corporation

Osteotech and Novation sign Single Source Agreement

Aastrom’s IND Phase III bags FDA approval for Treating Osteonecrosis of the

Femoral Head

ACT Uses Hemangioblasts to Reduce the Risk of Heart Attack

IsoTis Expands Existing Private Label Agreement with AlloSource for

First Generation DBM Products

RTI Signs Ten Year Distribution Agreement with Zimmer Holdings for

New Allograft Paste Implant

Tutogen Medical Inc. Signs Distribution Agreement with Zimmer Holdings Inc

Alphatec Holdings Acquires Technology License for Minimally Invasive

Spinal Surgery

Japanese Ministry Endorses Alphatec’s NOVEL Titanium Product Family

FDA Approval to Exactech for Distribution of Equinox® Reverse Shoulder

U.S. FDA Grants 510(k) Clearance to Osteotech for Plexur™ P

Advanced Cell Technology Buys Technology Assets of Infigen…

Bone Regeneration Phase II Clinical Trials Initiated by Kuros

FDA grants Orphan Drug Designation to Kuros’ New Bone Repair Product

Inion Product Range of BMI Widens with the Approval of ANCHRON™ in Europe

NuVasive Buys Biologic Product Platform

License Agreements between Alphatec and Scient’x for Manufacture and

Distribution of Spine Implants

University of Rochester and StemCapture Unveil an Anticancer

Stem Cell Implant Device.

Musculoskeletal Transplant Foundation Announces Three Year Deal

with Affinergy

Bioheart Inc. Expands Clinical Trials of Adult Myogenic Stem Cells

Encore Medical Acquires Cefar AB of Sweden

Pegasus Biologics’ Wound Dressing Receives FDA Approval

CryoLife Enters into Alliance with Bioform Medical for Development and

Marketing of BioGlue®

Stem Cell Innovations Enters into Collaboration with ND TWente University for Assessment

of Bone Forming Capability of Pluricells

Exactech Gains FDA Clearance for DBM with Bone Chips, OptecureTM +CCC

Affinergy Signs Development Agreement with Synthes

Affinergy Joins Hands with DuPont for New Bio-based Materials

Acquisition of Exclusive Option Rights of Cell Technology by Bioheart

Axordia Enters into Collaboration with Lombard Medical Technologies for Developing of

Therapy for Coronary Artery Disease

Smith & Nephew Buys OsteoBiologics Inc.

Acologix Announces Findings of the Initial Feasibility Study of AC-100

Bone Growth Stimulator - New Product of Alphatec Holdings.

Exactech Adds Cemented Stem to its Hip System

Avecia Given £1m Grant to Develop Bioprocessing Technology for

Generating Synthetic Skin for Burn Victims

Patent Licensing Agreement Signed between Bioheart and Tricardia

Inion’s Novel Bioactive Technology Granted with US Patent

Cytori Reveals Outcome of Adipose-derived Stem Cell Therapy

Alphatec Spine and OsteoBiologics Enter into an Agreement for

Distribution of Spine Products.

Bioheart Signs Agreement to Use Cleveland Clinic’s Proprietary Methods

Pegasus Launches OrthADAPT™ Bioimplant - a Revolutionary New Biologic Scaffold

for Orthopedic Soft Tissue Reinforcement

Cambrex Buys Cutanogen Corporation

Inion Enters into Alliance with Aesculap for Distribution of its Spinal Product Range Across

the US and Canada

Inion Enters into an Agreement with the University of Cambridge for Advancement of

Bioactive Products

Total ReCord Initiates Novel treatment for Spinal Cord Injuries

Inion and Richard Wolf Medical Instruments Enter into Agreement for

Distribution of Sports Medicine

International Distribution Agreement Signed by OsteoBiologics and CONMED Linvatec for

Cartilage and Bone Repair Product Range

Millenium Biologix Enters into License Agreement Exclusively to Improve ACTES(TM)-C

Inion Launches Biodegradable Spinal Implant in the EU

OsteoBiologics Enters into Collaboration with Nexa Orthopedics for Surgical Extremities

Affinergy Awarded SBIR Grant for Research on Medical Device Materials

Genzyme Acquires Verigen AG

CryoLife and Endologix Enter into a Development Agreement for BioFoam

5. Regional Market Analysis

A. NORTH AMERICA

Market Analysis

Exhibit 124: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Exhibit 125: List of Major Companies in North America Market Analysis by Geographic Region

Exhibit 126: Biological Implants (2005-2012) -North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)

Exhibit 127: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)

Analysis by Tissue/Muscle

Exhibit 128: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 129: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular, and Other (Graphical Representation Included)

Analysis by Origin

Exhibit 130: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 131: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 132: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 133: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

North American Biological Implants Market By Country

A1. United States

United States Market Analysis

Analysis by Tissue/Muscle

Exhibit 134: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 135: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the US Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 136: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 137: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of US Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 138: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 139: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of US Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

A2. Canada

Canadian Market Analysis

Analysis by Tissue/Muscle

Exhibit 140: Biological Implants (2005-2012) -Canadian Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 141: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 142: Biological Implants (2005-2012) - Canadian Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 143: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 144: Biological Implants (2005-2012) -Canadian Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 145: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

B. EUROPE

Market Analysis

Exhibit 146: Biological Implants (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Exhibit 147: List of Major Companies in Europe Market Analysis by Geographic Region

Exhibit 148: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 149: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)

Analysis by Tissue/Muscle

Exhibit 150: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 151: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular, and Other (Graphical Representation Included)

Analysis by Origin

Exhibit 152: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 153: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 154: Biological Implants (2005-2012) -European Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 155: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

European Biological Implants Market By Country

B1. Germany

German Market Analysis

Analysis by Tissue/Muscle

Exhibit 156: Biological Implants (2005-2012) - German Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 157: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 158: Biological Implants (2005-2012) - German Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 159: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 160: Biological Implants (2005-2012) - German Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 161: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

B2. The United Kingdom

UK Market Analysis

Analysis by Tissue/Muscle

Exhibit 162: Biological Implants (2005-2012) - United Kingdom Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million

Exhibit 163: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 164: Biological Implants (2005-2012) - United Kingdom Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 165: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 166: Biological Implants (2005-2012) - United Kingdom Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 167: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

B3. France

French Market Analysis

Analysis by Tissue/Muscle

Exhibit 168: Biological Implants (2005-2012) - French Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 169: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 170: Biological Implants (2005-2012) - French Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million(Graphical Representation Included)

Exhibit 171: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 172: Biological Implants (2005-2012) - French Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 173: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

B4. Switzerland

Swiss Market Analysis

Analysis by Tissue/Muscle

Exhibit 174: Biological Implants (2005-2012) - Swiss Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 175: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other (Graphical Representation Included)

Analysis by Origin

Exhibit 176: Biological Implants (2005-2012) - Swiss Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 177: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 178: Biological Implants (2005-2012) - Swiss Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 179: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

B5. Rest of Europe

Rest of Europe Market Analysis

Analysis by Tissue/Muscle

Exhibit 180: Biological Implants (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 181: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Tissue/Muscle for Soft Tissue, Orthopedic, Cardiovascular and Other

Analysis by Origin

Exhibit 182: Biological Implants (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 183: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 184: Biological Implants (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 185: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

C. ASIA-PACIFIC

Market Analysis

Exhibit 186: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Exhibit 187: List of Major Companies in Asia-Pacific Analysis by Geographic Region

Exhibit 188: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 189: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)

Analysis by Tissue/Muscle

Exhibit 190: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 191: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Tissue/Muscle for Orthopedic, Soft tissue, Cardiovascular and Other (Graphical Representation Included)

Analysis by Origin

Exhibit 192: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 193: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 194: Biological Implants (2005-2012) -Asia-Pacific Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 195: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

Asia-Pacific Biological Implants Market By Country

C.1. Australia

Australian Market Analysis

Analysis by Tissue/Muscle

Exhibit 196: Biological Implants (2005-2012) - Australian Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 197: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 198: Biological Implants (2005-2012) - Australian Market Analysis o(Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 199: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 200: Biological Implants (2005-2012) -Australian Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 201: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

C2. Japan

Japanese Market Analysis

Analysis by Tissue/Muscle

Exhibit 202: Biological Implants (2005-2012) - Japanese Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 203: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 204: Biological Implants (2005-2012) - Japanese Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 205: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 206: Biological Implants (2005-2012) -Japanese Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 207: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

C3. Rest of Asia-Pacific

Rest of Asia-Pacific Market Analysis

Analysis by Tissue/Muscle

Exhibit 208: Biological Implants (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 209: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 210: Biological Implants (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 211: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 212: Biological Implants (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 213: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

D. REST OF WORLD

Market Analysis

Exhibit 214: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Exhibit 215: List of Major Companies in Rest of World

Analysis by Geographic Region Exhibit 216: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of *World in US$ Million (Graphical Representation Included)

Exhibit 217: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

Analysis by Tissue/Muscle

Exhibit 218: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 219: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other (Graphical Representation Included)

Analysis by Origin

Exhibit 220: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 221: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 222: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 223: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

Rest of World Biological Implants Market By Country

D1. Israel

Israeli Market Analysis

Analysis by Tissue/Muscle

Exhibit 224: Biological Implants (2005-2012) - Israeli Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 225: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Israeli Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 226: Biological Implants (2005-2012) -Israeli Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 227: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Israeli Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 228: Biological Implants (2005-2012) -Israeli Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 229: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Israeli Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

D2.Brazil

Brazilian Market Analysis

Analysis by Tissue/Muscle

Exhibit 230: Biological Implants (2005-2012) - Brazilian Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 231: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other

Analysis by Origin

Exhibit 232: Biological Implants (2005-2012) - Brazilian Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 233: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 234: Biological Implants (2005-2012) - Brazilian Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 235: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

D3. Rest of World (Excluding Israel and Brazil)

Rest of World Market Analysis

Analysis by Tissue/Muscle

Exhibit 236: Biological Implants (2005-2012) - *Rest of World Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)

Exhibit 237: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of *Rest of World Market Value by Tissue/Muscle for Soft Tissue, Orthopedic, Cardiovascular and Other (Graphical Representation Included)

Analysis by Origin

Exhibit 238: Biological Implants (2005-2012) - *Rest of World Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)

Exhibit 239: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of *Rest of World Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)

Analysis by Mode of Administration

Exhibit 240: Biological Implants (2005-2012) - *Rest of World Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)

Exhibit 241: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of *Rest of World Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

6. Biological Implants - The Industry Outlook

V. CORPORATE DIRECTORY

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.